「fdA」の共起表現一覧(1語右で並び替え)
該当件数 : 536件
| y pled guilty to a single count of lying to the | FDA about the adverse effects of Metabolife 356. |
| In 2005 the U.S. Food and Drug Administration ( | FDA) accepted Cortex Pharmaceuticals' Investigation |
| In 2009, the | FDA added minocycline to its Adverse Event Reportin |
| A recipient of a 483 should respond to the | FDA, addressing each item, indicating agreement and |
| ily withdrawn from the market after a July 2005 | FDA advisory warned of a high overdose potential wh |
| United States on August 13, 2010, following the | FDA advisory committee's recommendation. |
| On September 8, 2010 the | FDA Advisory Committee recommended approval for the |
| Also in 2009, an | FDA advisory committee unanimously recommended Beva |
| FDA Advisory on star anise "teas" | |
| was banned by the Food and Drug Administration ( | FDA) after its carcinogenicity in rats was discover |
| and efficacy raised in the public comments, the | FDA again determined that the vaccine is licensed f |
| The | FDA alleges a relationship between prescriptions of |
| The | FDA also is requiring manufacturers to update label |
| The | FDA also made a policy that companies could not for |
| The authors of the | FDA analysis note that "given the large number of c |
| The U.S. Food and Drug Administration ( | FDA) and international health authorities have publ |
| lture (USDA), the Food and Drug Administration ( | FDA) and the Environmental protection agency (EPA). |
| that the Janus data repository would enable the | FDA and the pharmaceutical industry to both look re |
| by what they perceived as collusion between the | FDA and food conglomerates, put pressure on the FDA |
| ation (JPMA), the Food and Drug Administration ( | FDA), and the Pharmaceutical Research and Manufactu |
| ithKline is currently being investigated by the | FDA and the US Congress regarding Avandia. |
| ast few decades moving between Monsanto and the | FDA and USDA. |
| illapur facility facility was re-audited by the | FDA and approved, following the filing of an ANDA b |
| the only contraceptive implant approved by the | FDA and sold in the United States. |
| s" Revealed, Trudeau writes that workers at the | FDA and FTC want to censor him and, figuratively, b |
| thods are recognized as official methods by the | FDA and other agencies. |
| ablished in 1990, and is managed jointly by the | FDA and the CDC. |
| as received Orphan Drug designation by both the | FDA and the European Medicines Agency. |
| these years he worked with local organizations | FDA and FLOT, acting in community theatre and high |
| ication to the US Food and Drug Administration ( | FDA) and as a result of discussion with the FDA Jer |
| Following authorization by the | FDA and USDA, Castleberry's Food Company restarted |
| The | FDA and the manufacturer also warn that some patien |
| , outdoor laser use is jointly regulated by the | FDA and the Federal Aviation Administration. |
| Competitiveness and Regulation: The | FDA and the Future of America's Biomedical Industry |
| vestigational New Drug Application (IND) to the | FDA and began Phase I, II, and III clinical trials |
| r 2, 2009, the US Food and Drug Administration ( | FDA) and Sanofi-Aventis are warning healthcare prof |
| ults of the full analyses were disclosed to the | FDA and reflected on the Vioxx warning label. |
| roved by the U.S. Food and Drug Administration ( | FDA) and is a leading example of personalized medic |
| cers, packagers, handlers) to register with the | FDA and pay an annual fee of $500 per facility. |
| the United States Food and Drug Administration ( | FDA) announced that Elidel packaging would be requi |
| 8, 2009, the U.S. Food and Drug Administration ( | FDA) announced that Coartem was approved for the tr |
| The U.S. Food and Drug Administration ( | FDA) announced on 2 June 2009 that the drug has bee |
| er 2007, the U.S. Food and Drug Administration ( | FDA) announced that a warning about possible deafne |
| In September 2010 and appeal, the | FDA announced that it would begin regulating e-ciga |
| On the same day as the | FDA announcement, Novartis Pharmaceuticals Canada a |
| The | FDA anticipates completing its review of this appli |
| On April 28, 2011, the | FDA Antiviral Drugs Advisory Committee voted 18-0 t |
| Due to frequent controversies involving the | FDA, appointments are not always prompt and the age |
| Adeza Biomedical (October 23, 2006) Receives | FDA Approvable Letter For Gestiva |
| Ipodate sodium lacks | FDA approval for this use. |
| atin, obtained US Food and Drug Administration ( | FDA) approval in 1978 and went on to become a widel |
| Geigy gained | FDA approval for the drug in December 1986. |
| Olsalazine gained Food and Drug Administration ( | FDA) approval in 1990. |
| al for the new drug, and the drug received full | FDA approval on August 6, 2007 for use in treatment |
| October 5, 2000, Pharmacia received | FDA approval for Lunelle Monthly Contraceptive Inje |
| ery procedures, and the work of his team led to | FDA approval for cardiac robotic techniques includi |
| vine collagen for wrinkles and scars helped get | FDA approval and launched the highly profitable fie |
| In March 2011, Daliresp gained | FDA approval in the US for reducing COPD exacerbati |
| Its | FDA approval helped bring down the price of zidovud |
| It gained Food and Drug Administration ( | FDA) approval in April 1998, and is supplied by Mer |
| Ultimately, MAPS seeks to achieve | FDA approval for the use of MDMA as a prescription |
| Ligand gained Food and Drug Administration ( | FDA) approval for alitretinoin in February 1999. |
| Floxuridine first gained | FDA approval in December 1970 under the brand name |
| a (who had by then merged with Upjohn) received | FDA approval for the use of epirubicin as a compone |
| vaccines against HPV, the first of which earned | FDA approval in 2006. |
| ns of NRTIs was in practice prior to the second | FDA approval and the triple drug combinations with |
| Mylan Laboratories Inc. has received | FDA approval for its generic version of Imitrex tab |
| first quarter 2010, Genasense had not received | FDA approval due to disappointing results in a mela |
| e III of the U.S. Food and Drug Administration ( | FDA) approval process. |
| Amgen Puerto Rico received | FDA approval for bulk manufacturing facilities for |
| Because of this trial Sorafenib obtained | FDA approval for the treatment of advanced hepatoce |
| ial is required before it can be considered for | FDA approval in the United States. |
| Upjohn filed for | FDA approval of streptozotocin as a treatment for p |
| Requires | FDA approval for the use of expressions such as "li |
| through the U.S. Food and Drug Administration ( | FDA) approval process |
| mmon form of liver cancer, in October 2007, and | FDA approval for this indication followed in Novemb |
| It received | FDA approval in 1991. |
| in the U.S. due to toxicity and never received | FDA approval. |
| is drug, under the trade name Lucentis, now has | FDA approval. |
| ss experimental medications before they receive | FDA approval. |
| Inc., and was brought to market in 2005, after | FDA approval. |
| sfully complete clinical development and obtain | FDA approval. |
| te a phase III trial (CONCERT study) aiming for | FDA approval. |
| FDA approved tagatose as a food additive in October | |
| In the U.S. the | FDA approved its use in wines in 1988, with the max |
| FDA approved this drug on October 9th, 2008. | |
| If the | FDA approved a system like UltraShape or SonoSculpt |
| It is not | FDA approved to be used in children. |
| On April 27, 2006, | FDA approved labeling changes concerning all form o |
| The study by Taylor et al., based on which the | FDA approved the medication demonstrated that isoso |
| It is supplied in | FDA approved food grade. |
| breakthroughs and discoveries in medicine, the | FDA approved lifesaving treatment for Pompe disease |
| It is an U.S. Food and Drug Administration ( | FDA) approved human monoclonal antibody developed b |
| ment Yellow 42 is Food and Drug Administration ( | FDA) approved for use in cosmetics and is used in s |
| Visualase is not | FDA approved for use in any specific cancer treatme |
| On February 28, 2008, the | FDA approved a controlled-release formulation of fl |
| sitagliptin ( | FDA approved 2006, marketed by Merck & Co. as Januv |
| On April 15, 2008, the US | FDA approved a combination of sumatriptan and napro |
| the brand name Fareston, toremifene citrate is | FDA approved for use in advanced (metastatic) breas |
| It is the only | FDA approved drug to treat primary biliary cirrhosi |
| The | FDA approved it October 20, 2003, while the EMEA ap |
| of 1986, the U.S. Food and Drug Administration ( | FDA) approved it. |
| In 1970 the U.S. Food and Drug Administration ( | FDA) approved LAL for testing drugs, products and d |
| plant natural product beta-caryophyllene is an | FDA approved food additive and ingested daily with |
| VLPs have already been used to develop | FDA approved vaccines for Hepatitis B and human pap |
| The | FDA approved the drug for antidepressant use in Feb |
| The US | FDA approved it for treatment of hyperammonaemia on |
| In 2010 the US | FDA approved the use of Lucentis injections for mac |
| Medications are not | FDA approved for use in this age group. |
| Undecylenic acid is a natural fungicide and is | FDA approved in over-the-counter medications for sk |
| The | FDA approved Seroquel XR for the treatment of bipol |
| On February 22, 2005, the US | FDA approved a sustained release form of doxazosin, |
| The U.S. Food and Drug Administration ( | FDA) approved dextromethorphan for over-the-counter |
| The services are US | FDA approved and tested in-house, and conform to th |
| tes (U.S.) with a Food and Drug Administration ( | FDA) approved indication for the treatment of restl |
| FDA approved application number (note that “other” | |
| On August 22, 2008, the | FDA approved romiplostim as a long-term treatment f |
| panies globally, primarily using one of the two | FDA approved technologies. |
| In 2001 the U.S. | FDA approved a proprietary formula of a solution of |
| The Food and Drug Administration ( | FDA) approved the sale of a generic version of Flon |
| 2, 2008, the U.S. Food and Drug Administration ( | FDA) approved Cimzia for use in the United States f |
| The first orphan-drug for Genzyme that | FDA approved was Ceredase, a drug for treating Gauc |
| The U.S. Food and Drug Administration ( | FDA) approved human clinical trials for the intra-v |
| The Food and Drug Administration ( | FDA) approved its sale as an over-the-counter treat |
| the body) in select patients although it is not | FDA approved for this use. |
| In March 2009, the | FDA approved the use of Symbicort pMDI to treat chr |
| The Food and Drug Administration ( | FDA) approved indinavir March 13, 1996, making it t |
| All ingredients are USDA and | FDA approved and the process has been licensed by t |
| ay 2003, the U.S. Food and Drug Administration ( | FDA) approved Ibandronate as a daily treatment for |
| 24, 2008, the US Food and Drug Administration ( | FDA) approved difluprednate for the treatment of po |
| It is | FDA approved for treating chronic lymphocytic leuke |
| used in a host of Food and Drug Administration ( | FDA) approved therapeutic devices, owing to its bio |
| It is not | FDA approved for human use as an antiarrhythmic age |
| Ertapenem ( | FDA approved - for multiple indications) |
| lled BVA-100, Blood Volume Analysis is the only | FDA approved instrument that provides a measure of |
| It gained | FDA Approved in July 1969. |
| US | FDA approves Cipla's bulk drug manufacturing facili |
| cess by which the Food and Drug Administration ( | FDA) approves a biological for commercial distribut |
| In the U.S., true soaps (as defined by the | FDA) are specifically exempted from INCI labeling r |
| en defined by the Food and Drug Administration ( | FDA) as "a predictive mathematical model describing |
| ealth Level Seven (HL7) and has been adopted by | FDA as a mechanism for exchanging medication inform |
| tary restrictions are currently required by the | FDA, as a precaution, at the higher 9 mg/24h and 12 |
| brand name "Lean Cuisine" is considered by the | FDA as a nutrient content claim, so all Lean Cuisin |
| Diphenhydramine is approved by the | FDA as an antihistamine as well as a sleep aid, and |
| It was approved May 31, 1996 by the | FDA as being effective for three years; it was subs |
| However, the THC pill Marinol was cited by the | FDA as being responsible for 4 of the 11,687 deaths |
| ey Shuren is the director of the CDRH at the US | FDA as of January 2010. |
| val from the U.S. Food and Drug Administration ( | FDA) as a birth control method. |
| Vaniqa, granted marketing approval by the US | FDA, as well as by the European Commission among ot |
| lic Citizen filed a Citizen's Petition with the | FDA, asking that Crestor be withdrawn from the US m |
| The US | FDA at the end of 2006 approved the use OHCbl as an |
| ing small-farm and farmer's markets provide for | FDA authority to exempt farms engaged in low or no |
| The law gives the Food and Drug Administration ( | FDA) authority to require nutrition labeling of mos |
| Citizen released a petition requesting that the | FDA ban oral contraceptives containing desogestrel, |
| ficient amounts of safrole to be covered by the | FDA ban. |
| me, failed to provide this information, and the | FDA banned the use of cervical caps in the United S |
| the U.S. when the Food and Drug Administration ( | FDA) banned flavor descriptors such as "mild," "lig |
| The descriptor change occurred because the | FDA banned product descriptors such as "Light," "Ul |
| nown as belatacept was recently approved by the | FDA based on favorable results from the randomized |
| The | FDA began regulatory action against five American c |
| ed by President Bill Clinton, she served at the | FDA between 1998 and 2001. |
| ade these arguments in petitions filed with the | FDA, but the FDA rejected those petitions. |
| ium is not approved in the United States by the | FDA, but it has been approved in the European Union |
| book was ordered to be burned on request of the | FDA by a Maine judge in 1956, amongst other works b |
| Tipifarnib was submitted to the | FDA by Johnson & Johnson for the treatment of AML i |
| ents, and that bioavailability is the only test | FDA can require. |
| If a signal is detected, the | FDA can issue medical product safety alerts or orde |
| he Blood Products Advisory Committee within the | FDA Center for Biologics Evaluation and Research, a |
| Letter recommendations from district offices to | FDA Centers. |
| ncies like the US Food and Drug Administration ( | FDA), changed in status and have since been removed |
| INVO Bioscience plans to start the | FDA clearance process this year. |
| is process being completed within the year with | FDA clearance in 2011. |
| , and received US Food and Drug Administration ( | FDA) clearance to market for the Waldo Health Syste |
| It is | FDA cleared to necrotize soft tissue under MRI guid |
| o perform LASIK surgery as part of the original | FDA clinical trials. |
| The | FDA closed its medical marijuana IND program (the C |
| ng to the National Psoriasis Foundation and the | FDA, coal tar is a valuable, safe and inexpensive t |
| Recently, Graham and one of his | FDA colleagues, Kate Gelperin, have called for the |
| For the above analysis, the | FDA combined the results of 295 trials of 11 antide |
| FDA Commissioner Alexander Schmidt defended the dye | |
| ports have indicated he is a finalist to become | FDA commissioner in the new administration. |
| dent, but we can hardly take that chance," said | FDA Commissioner Frank E. Young. |
| would block his nomination to be the permanent | FDA commissioner because of his department's failur |
| ry of Commerce, and David Aaron Kessler, former | FDA Commissioner, along with other notable figures |
| Walter G. Campbell from the list of | FDA Commissioners in history (he was commish in 20' |
| A review of literature by an | FDA committee found no evidence of carcinogenicity, |
| On May 17, 1994, the | FDA completed its evaluation of the Flavr Savr toma |
| ture ranges, U.S. Food and Drug Administration ( | FDA) compliance, and plastic compatibility. |
| Rulon 1439, white, | FDA compliant for use in submerged applications wit |
| The | FDA concluded that there was inadequate evidence on |
| FDA concludes that there is little scientific evide | |
| When the | FDA conducted an inspection of Baxter's Chinese Hep |
| The | FDA considers such items "adulterated cosmetics" an |
| The United States | FDA considers citronellol as generally recognized a |
| fied healthcare professionals and patients that | FDA continues to receive reports of methemoglobinem |
| In 1997, the U.S. | FDA created an incentive for generics companies to |
| By April 2008, independent analysis using | FDA data has linked Ketek (Telithromycin) to 18 dea |
| but on March 30, 2010, the | FDA declined to approve use of Nuvigil to treat jet |
| In November 2008 the US | FDA declined to approve Ceftobiprole citing data in |
こんにちは ゲスト さん
ログイン |
Weblio会員(無料)になると
|
検索履歴を保存できる！
こんにちは ゲスト さん
|
ログイン |
Weblio会員(無料)になると
|
